Zusammenfassung
In diesem Kapitel werden die in der Pädiatrie klinisch relevanten Systemmykosen (Aspergillose, Candidose, Kryptokokkose und Mucormykose) behandelt. Für seltene invasive und disseminierte Pilzinfektionen, die in Mitteleuropa keine Rolle spielen (Kokzidioidomykose, Parakokzidioidomykose, Histoplasmose, Blastomykose u. a.), wird auf die mykologische und infektiologische Spezialliteratur verwiesen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
American Academy of Pediatrics (ed) (2012) Red Book: report of the Committee on Infectious Diseases, 29th edn. American Academy of Pediatrics, Elk Grove Village
Cohen-Wolkowiez M, Benjamin DK Jr, Piper L et al. (2011) Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonates. Clin Pharmacol Ther 89: 702–707
Cornely OA, Maertens J, Winston DJ et al. (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356: 409–411
Gallin JI, Alling DW, Malech HL et al. (2003) Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 348: 2416–2422
Merlin E, Galambrun C, Ribaud P et al. (2006) Efficacy and safety of caspofungin therapy in children with invasive fungal infections. Pediatr Infect Dis J 12: 1186–1188
Notheis G, Tarani L, Costantino F et al. (2006) Posaconazole for treatment of refractory invasive fungal disease. Mycoses 49: S37–41
Pappas PG, Kauffmann CA, Andes D et al. (2009) Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 48: 503–535
Perfect JR, Dismukes WE, Dromer F et al. (2010) Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 50: 291–322
Segal BH, Walsh TJ (2005) Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 173: 707–717
Skiada A, Pagano L, Groll A, et al.; European Confederation of Medical Mycology Working Group on Zygomycosis (2011) Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 17:1859–1867. doi: 10.1111/j.1469-0691.2010.03456.x
Steinbach W, Walsh T (2006) Mycoses in pediatric patients. Infect Dis Clin N Am 20: 663–678
Van Burik J, Hare R, Solomon H, Corrado M, Kontoyiannis D (2006) Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 42: e61–65
Varisco BM, Benner KW, Prabhakaran P (2009) Neonatal peritoneal candidiasis successfully treated with anidulafungin add-on therapy. Ann Pharmacother 43:1907–1910
Walsh TJ, Finberg RW, Arndt C et al. for the National Institute of Allergy and Infectious Diseases Mycoses Study Group (1999) Liposomal Amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 340: 764–7710
Walsh TJ, Anaissie EJ, Denning DW et al. (2008) Treatment of aspergillosis: Clinical Practice Guidelines of the Infectious Disease Society of America. Clin Infect Dis 46: 327–360
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Weiß, M., Wintergerst, U., Müller, A. (2014). Systemische Pilzinfektionen. In: Reinhardt, D., Nicolai, T., Zimmer, KP. (eds) Therapie der Krankheiten im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41814-3_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-41814-3_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41813-6
Online ISBN: 978-3-642-41814-3
eBook Packages: Medicine (German Language)